Vitamin D3 for Life

Live Enlightened

Research libraryVitamin D3 For Life
Study design and methods

Secondary relevance to vitamin D This paper mainly addresses another topic and also reports a vitamin D analysis, result or scientific synthesis.

This paper mainly addresses another topic and also reports a vitamin D analysis, result or scientific synthesis.

Why this paper is included

Supporting source evidence:

Additionally, several known fibroid risk factors were also associated with fibroid status, including disorders of menstruation and other abnormal bleeding from female genital tract (ORmulti = 6.45, 95% CI = 6.13 to 6.78, p-value = 5.60 × 10⁻¹¹³⁰), endometriosis (ORmulti = 7.89, 95% CI = 7.02 to 8.88, p-value = 2.59 × 10⁻²⁵⁸), diagnoses of overweight, obesity, and other hyperalimentation (ORmulti = 1.52, 95% CI = 1.45 to 1.60, p-value = 2.21 × 10−58), disorders of lipid metabolism (ORmulti = 1.47, 95% CI = 1.40 to 1.54, p-value = 4.61 × 10⁻⁵⁹), and vitamin D deficiency (ORmulti = 1.43, 95% CI = 1.35 to 1.51, p-value = 4.49 × 10⁻³⁶).

Source: Multi-population SD and GHS meta-analyses. View original paper

Relevance classification does not establish study quality, causation or editorial approval.

Study design Study design awaiting verification.

Study design awaiting verification

The available source does not establish a sufficiently clear study design.

Meta-analysis unclear · Blinding unclear / not reported · Human research reported

How this paper was classified

Automatic source-based classification; awaiting editorial verification. This is not a quality score.

As all data was de-identified, this study was deemed non-human subjects research and approved by Vanderbilt University Medical Center Institutional Review Board.

Source: Methods.

View supporting evidence in the original paper

What the study types mean
Systematic review
Uses explicit methods to identify, assess and summarise research on a defined question.
Scoping review
Maps the extent and characteristics of research on a topic.
Narrative review
Discusses existing research; systematic-review methods have not been established by this classification.
Review / evidence synthesis
Reviews existing research; the exact review methods need further assessment.
Randomised controlled trial
Assigns participants or groups to comparison interventions by chance.
Non-randomised intervention study
Examines an intervention without random allocation.
Cohort study
Examines exposures and outcomes over time within a defined group.
Case-control study
Compares people with an outcome against people without it, examining exposures.
Cross-sectional study
Examines a population at a particular point in time.
Observational study
Observes exposures and outcomes without assigning the exposure; the subtype is not established here.
Case report
Describes an individual case.
Case series
Describes a group of individual cases.
Secondary analysis
Analyses existing study data; this paper is not automatically another independent trial.
Laboratory study
Investigates biological processes in a laboratory setting.
Qualitative study
Examines experiences or meanings using qualitative methods.
Genetic instrumental-variable study
Uses genetic variation as an instrument to investigate relationships; this is not a randomised treatment trial.
Study protocol
Describes planned methods and is not evidence that the planned study has reported results.
Multiple reported designs
More than one design is explicitly reported; examine the supporting methods.
Study design awaiting verification
The available source does not establish a sufficiently clear study design.

Meta-analysis combines numerical results from studies. Blinding describes who was unaware of treatment allocation. Neither is a separate quality grade. Study design, vitamin D relevance and document format are independent filters.

Abstracts

A phenome-wide association study of uterine fibroids reveals a marked burden of comorbidities

Study design awaiting verification · Communications Medicine · 2025

Original publication title

A phenome-wide association study of uterine fibroids reveals a marked burden of comorbidities

Elizabeth A. Jasper; Brian S. Mautz; Jacklyn N. Hellwege; Jacqueline A. Piekos; Sarah H. Jones; Yanfei Zhang; Eric S. Torstenson; Sarah A. Pendergrass; Ming Ta Michael Lee; Todd L. Edwards; Digna R. Velez Edwards

© The Author(s) 2025

Original publication · Publisher record · CC BY 4.0

Source wording retained. Formatting, section navigation and display-title punctuation adapted for this research record.

Authors’ conclusion

Overall, individuals with fibroids have a marked increase in comorbidities compared to those without fibroids. This approach to evaluate the health context of fibroids highlights the potential to understand fibroid etiology through studying the common biology of comorbid diagnoses and through disease networks.

An extract from the source publication. Read it in context.

At a glance

Abstract: What background does the paper provide?

The burden of comorbidities in those with uterine fibroids compared to those without fibroids is understudied. We performed a phenome-wide association study to systematically assess the association between fibroids and other conditions.

Source: Background

Abstract: What methods does the paper describe?

Vanderbilt University Medical Center’s Synthetic Derivative and Geisinger Health System Database, two electronic health record databases, were used for discovery and validation. Non-Hispanic Black and White females were included. Fibroid cases were identified through a previously validated algorithm. Race-stratified and multi-population phenome-wide association analyses, adjusting for age and body mass index, were performed before statistically significant, validated results were meta-analyzed.

Source: Methods

Abstract: Results

There were 52,295 and 26,918 (9022 and 10,232 fibroid cases) females included in discovery and validation analyses. In multi-population meta-analysis, 389 conditions were associated with fibroid risk, with evidence of enrichment of circulatory, dermatologic, genitourinary, musculoskeletal, and sense organ conditions. The strongest associations within and across racial groups included conditions previously associated with fibroids. Numerous novel diagnoses, including cancers in female genital organs, were tied to fibroid status.

Source: Results

Abstract: Conclusions

Overall, individuals with fibroids have a marked increase in comorbidities compared to those without fibroids. This approach to evaluate the health context of fibroids highlights the potential to understand fibroid etiology through studying the common biology of comorbid diagnoses and through disease networks.

Source: Conclusions
Authors’ abstract

Background

The burden of comorbidities in those with uterine fibroids compared to those without fibroids is understudied. We performed a phenome-wide association study to systematically assess the association between fibroids and other conditions.

Methods

Vanderbilt University Medical Center’s Synthetic Derivative and Geisinger Health System Database, two electronic health record databases, were used for discovery and validation. Non-Hispanic Black and White females were included. Fibroid cases were identified through a previously validated algorithm. Race-stratified and multi-population phenome-wide association analyses, adjusting for age and body mass index, were performed before statistically significant, validated results were meta-analyzed.

Results

There were 52,295 and 26,918 (9022 and 10,232 fibroid cases) females included in discovery and validation analyses. In multi-population meta-analysis, 389 conditions were associated with fibroid risk, with evidence of enrichment of circulatory, dermatologic, genitourinary, musculoskeletal, and sense organ conditions. The strongest associations within and across racial groups included conditions previously associated with fibroids. Numerous novel diagnoses, including cancers in female genital organs, were tied to fibroid status.

Conclusions

Overall, individuals with fibroids have a marked increase in comorbidities compared to those without fibroids. This approach to evaluate the health context of fibroids highlights the potential to understand fibroid etiology through studying the common biology of comorbid diagnoses and through disease networks.

Plain language summary

Though many females have uterine fibroids, not enough is known about how fibroids affect people’s health compared to those who do not have them. We explored fibroids’ connection to many other health conditions using information from electronic health records and groups of people from different races. Across all groups, we found over 380 conditions were associated with fibroids. Many of these health issues were circulatory, skin, genital and urinary, musculoskeletal, and sense organ conditions. In addition to strong known associations, we also found many diagnoses that have not been associated with fibroids, like cancers in female genitals.

Overall, individuals with fibroids have more health conditions compared to those without fibroids. Our approach can help us to understand causes and consequences of fibroids.

Jasper and Mautz et al. systematically assess associations between uterine fibroids and hundreds of conditions using electronic health record databases. They identify numerous associations, both known and novel, and find that individuals with fibroids have more comorbidities compared to those without fibroids.

Publication and source details

Original title: A phenome-wide association study of uterine fibroids reveals a marked burden of comorbidities

Elizabeth A. Jasper; Brian S. Mautz; Jacklyn N. Hellwege; Jacqueline A. Piekos; Sarah H. Jones; Yanfei Zhang; Eric S. Torstenson; Sarah A. Pendergrass; Ming Ta Michael Lee; Todd L. Edwards; Digna R. Velez Edwards

Communications Medicine · 2025

© The Author(s) 20252025https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.https://doi.org/10.13039/100000002U.S. Department of Health & Human Services | National Institutes of Health (NIH)R01HD074711R03HD078567R01HD0936711R01HD112169-01A1K12HD043483K12HD043483Jasper Elizabeth A. Hellwege Jacklyn N. Edwards Todd L. https://doi.org/10.13039/100000054U.S. Department of Health & Human Services | NIH | National Cancer Institute (NCI)T32CA160056Mautz Brian S. https://doi.org/10.13039/100007206Vanderbilt Institute for Clinical and Translational Research (VICTR)5KL2-RR024977Lee Ming Ta Michael https://doi.org/10.13039/100006108U.S. Department of Health & Human Services | NIH | National Center for Advancing Translational Sciences (NCATS)5KL2-RR024977Edwards Todd L.

Repository JATS snapshot; version as supplied

Source retrieved: 2026-11-11T05:09:39.893471+00:00

DOI: 10.1038/s43856-025-00884-w · PMC12081880